Skip to main content

Table 1 Baseline characteristics of the patients

From: Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?

Age in years, mean (SD)

54.8 (14)

Symptom duration in months (n = 166)

4.6

Gender, % female

64%

DAS28, mean (SD)

4.9 (1.3)

SJC28 at baseline

6 (3–11)

TJC28 at baseline

6 (2–10)

ESR (n = 173)

27 (12–47)

VAS, mean (SD)

51 (24)

RF, % positive (n = 171)

67%

aCCP, % positive (n = 171)

60%

RF and aCCP, % positive (n = 171)

54%

HAQ (n = 155),

0.88 (0.38–1.25)

USJC

5 (2–9)

  1. n = 174, unless specified otherwise
  2. Median (interquartile range) are presented unless specified otherwise
  3. aCCP anti-cyclic citrullinated peptide, DAS Disease Activity Score, ESR erythrocyte sedimentation rate, HAQ Health Assessment Questionnaire, RF rheumatoid factor, SD standard deviation, SJC swollen joint count, TJC tender joint count, USJC ultrasonographic joint count, VAS visual analogue scale